Michele Moschetta

Michele Moschetta has extensive experience in the biomedical research and clinical development sectors, having held key positions at AstraZeneca from January 2017 to August 2020, including Executive Director of Early Clinical Development Oncology and Medical Science Director. Following this, Michele worked at CHUV | Lausanne University Hospital as Responsable de recherche clinique for a brief period before joining Novartis Institutes for BioMedical Research (NIBR) in January 2021, where roles included Senior Clinical Program Leader and Clinical Program Leader until November 2023. Additionally, Michele served as an Honorary Clinical Research Fellow at Cambridge University Hospitals NHS Foundation Trust from December 2017 to August 2020. Academically, Michele earned a PhD in Biomedical Sciences, specializing in Oncology and Cancer Biology, from Università degli Studi Bari and holds an MD from the same institution, completing the Internal Medicine Residency Program.